← Back to Search

Behavioral Intervention

mHealth App for Psychosis

N/A
Recruiting
Led By Benjamin Buck, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 weeks, 12 weeks
Awards & highlights

Study Summary

This trial will test a mobile health app to help young people at risk for psychosis to improve their health and connect to treatment options.

Who is the study for?
This trial is for young adults aged 18-30 in the U.S. who are at risk for psychosis but haven't been treated with antipsychotic meds or regular psychotherapy recently. They must own an iPhone and be within five years of their first psychotic episode or symptom onset.Check my eligibility
What is being tested?
The study tests a mobile health intervention, NORTH, designed to help those at risk for psychosis. It compares the full version (with lessons, practices, tracking, and help-seeking resources) against a 'Lite' version that lacks help-seeking features.See study design
What are the potential side effects?
Since this trial involves a digital intervention rather than medication, traditional side effects aren't expected. However, users may experience discomfort or stress from self-monitoring symptoms or engaging with mental health content.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 weeks, 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 weeks, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in internalized stigma
Change in perceived stress
Change in resilience / coping
+2 more
Secondary outcome measures
Change in functioning
Change in recovery
Change in symptoms
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: NORTH "Lite"Experimental Treatment1 Intervention
Participants in the control arm will be provided access to the NORTH "Lite" smartphone application designed to support young adults at risk for psychosis. They will also have access to the research team by phone for technical troubleshooting and support as necessary.
Group II: NORTHExperimental Treatment1 Intervention
Participants in the experimental arm will be provided access to the "Full" NORTH smartphone application designed to support young adults at risk for psychosis. They will also have access to the research team by phone for technical troubleshooting and support as necessary.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,749 Previous Clinical Trials
1,838,584 Total Patients Enrolled
2 Trials studying Psychosis
660 Patients Enrolled for Psychosis
National Institute of Mental Health (NIMH)NIH
2,798 Previous Clinical Trials
2,660,858 Total Patients Enrolled
46 Trials studying Psychosis
10,683 Patients Enrolled for Psychosis
Benjamin Buck, PhDPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
60 Total Patients Enrolled

Media Library

NORTH (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05905601 — N/A
Psychosis Research Study Groups: NORTH, NORTH "Lite"
Psychosis Clinical Trial 2023: NORTH Highlights & Side Effects. Trial Name: NCT05905601 — N/A
NORTH (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05905601 — N/A
~22 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top